Yunkang Group Limited (HKG:2325)
Hong Kong
· Delayed Price · Currency is HKD 0.770
-0.010 (-1.28%)
Apr 29, 2026, 4:08 PM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 450.72 million as of April 29, 2026. Its market cap has decreased by -76.16% in one year.
Market Cap
450.72M
Enterprise Value
-667.11M
Revenue
669.23M
Ranking
n/a
PE Ratio
138.72
Stock Price
0.77
Market Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 450.72M, a decrease of -91.35%. That is a compound annual growth rate of -46.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 456.57M | -21.21% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biosino Bio-Technology and Science Incorporation | 499.24M |
| China Biotech Services Holdings | 663.50M |
| Kindstar Globalgene Technology | 1.17B |
| King International Investment | 155.44M |
| China Health Group | 136.36M |
| Mega Genomics | 1.57B |
| Adicon Holdings | 2.81B |
| Guanze Medical Information Industry (Holding) | 6.56B |